Publications

Journal Article Epublish 14 citations
Electronic publication date
February 17, 2021

View on Pubmed.gov 32824279 | View on doi.org 10.3390/ijms211...

-(2'-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells.

Search for publications in this journal Int J Mol Sci

Abstract

-(2'-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) is a VPA derivative designed to be a histone deacetylase (HDAC) inhibitor. HO-AAVPA has better antiproliferative effect than VPA in cancer cell lines. Therefore, in this work, the inhibitory effect of HO-AAVPA on HDAC1, HDAC6, and HDAC8 was determined by in silico and in vitro enzymatic assay. Furthermore, its antiproliferative effect on the cervical cancer cell line (SiHa) and the translocation of HMGB1 and ROS production were evaluated. The results showed that HO-AAVPA inhibits HDAC1, which could be related with HMGB1 translocation from the nucleus to the cytoplasm due to HDAC1 being involved in the deacetylation of HMGB1. Furthermore, an increase in ROS production was observed after the treatment with HO-AAVPA, which also could contribute to HMGB1 translocation. Therefore, the results suggest that one of the possible antiproliferative mechanisms of HO-AAVPA is by HDAC1 inhibition which entails HMGB1 translocation and ROS increased levels that could trigger the cell apoptosis.

References

Oncotarget. 2018 Sep 7;9(70):33368-33381

Oncogene. 2010 Sep 23;29(38):5299-310

J Enzyme Inhib Med Chem. 2016;31(sup3):140-149

Mol Cancer Ther. 2008 Oct;7(10):3285-97

Cited by 14 citations (total)

Journal Article

Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines.

Electronic publication date November 1, 2023

Search for publications in this journal Int J Mol Sci

Alan Rubén Estrada-Pérez [...] José Correa-Basurto et al.

Breast cancer (BC) is one of the biggest health problems worldwide, characterized by intricate metabolic and biochemical complexities stemming from...

Journal Article

-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression.

Electronic publication date August 10, 2024

Search for publications in this journal Molecules

Berenice Prestegui Martel [...] José Correa Basurto et al.

In this work, we performed anti-proliferative assays for the compound -(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) on breast cancer (BC) cells (MCF-7, SKBR3, and...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances